62 related articles for article (PubMed ID: 14666121)
21. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
[TBL] [Abstract][Full Text] [Related]
22. [The clinical value of quantification of glucocorticoid receptors in peripheral blood mononuclear cells in myasthenia gravis].
Zhang X; Xu X; Yin J; Wang H; Guo H; Zhang H
Zhonghua Nei Ke Za Zhi; 2002 May; 41(5):322-4. PubMed ID: 12133426
[TBL] [Abstract][Full Text] [Related]
23. Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder.
Berlant JL
BMC Psychiatry; 2004 Aug; 4():24. PubMed ID: 15315714
[TBL] [Abstract][Full Text] [Related]
24. Synergism between topiramate and budipine in refractory status epilepticus in the rat.
Fisher A; Wang X; Cock HR; Thom M; Patsalos PN; Walker MC
Epilepsia; 2004 Nov; 45(11):1300-7. PubMed ID: 15509230
[TBL] [Abstract][Full Text] [Related]
25. Topiramate: effect on EEG interictal abnormalities and background activity in patients affected by focal epilepsy.
Placidi F; Tombini M; Romigi A; Bianchi L; Izzi F; Sperli F; Mattia D; Cervellino A; Marciani MG
Epilepsy Res; 2004 Jan; 58(1):43-52. PubMed ID: 15066674
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic interaction study between eslicarbazepine acetate and topiramate in healthy subjects.
Nunes T; Sicard E; Almeida L; Falcão A; Rocha JF; Brunet JS; Lefebvre M; Soares-da-Silva P
Curr Med Res Opin; 2010 Jun; 26(6):1355-62. PubMed ID: 20377319
[TBL] [Abstract][Full Text] [Related]
27. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication.
Kockelmann E; Elger CE; Helmstaedter C
Epilepsy Behav; 2004 Oct; 5(5):716-21. PubMed ID: 15380124
[TBL] [Abstract][Full Text] [Related]
28. Differential transcriptional response following glucocorticoid activation in cultured blood immune cells: a novel approach to PTSD biomarker development.
Breen MS; Bierer LM; Daskalakis NP; Bader HN; Makotkine I; Chattopadhyay M; Xu C; Buxbaum Grice A; Tocheva AS; Flory JD; Buxbaum JD; Meaney MJ; Brennand K; Yehuda R
Transl Psychiatry; 2019 Aug; 9(1):201. PubMed ID: 31434874
[TBL] [Abstract][Full Text] [Related]
29. [Topiramate for the treatment of post traumatic stress disorder. A case study].
Aalbersberg CF; Mulder JM
Tijdschr Psychiatr; 2006; 48(6):487-91. PubMed ID: 16956009
[TBL] [Abstract][Full Text] [Related]
30. Effects of topiramate on neurophysiological and neuropsychological tests in migraine patients.
Kececi H; Atakay S
J Clin Neurosci; 2009 Dec; 16(12):1588-91. PubMed ID: 19793661
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.
Silberstein SD; Hulihan J; Karim MR; Wu SC; Jordan D; Karvois D; Kamin M
Clin Ther; 2006 Jul; 28(7):1002-11. PubMed ID: 16990078
[TBL] [Abstract][Full Text] [Related]
32. Substantia nigra is an anticonvulsant site of action of topiramate in the focal pilocarpine model of limbic seizures.
Meurs A; Clinckers R; Ebinger G; Michotte Y; Smolders I
Epilepsia; 2006 Sep; 47(9):1519-35. PubMed ID: 16981869
[TBL] [Abstract][Full Text] [Related]
33. Topiramate effects on plasma serotonin levels in children with epilepsy.
Grosso S; Blardi P; Battaglini M; Franzoni E; De Lalla A; Mostardini R; Balestri P
Epilepsy Res; 2008 Oct; 81(2-3):148-54. PubMed ID: 18603411
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of transient and persistent Na+ current fractions by the new anticonvulsant topiramate.
Taverna S; Sancini G; Mantegazza M; Franceschetti S; Avanzini G
J Pharmacol Exp Ther; 1999 Mar; 288(3):960-8. PubMed ID: 10027832
[TBL] [Abstract][Full Text] [Related]
35. Increased peripheral NF-κB pathway activity in women with childhood abuse-related posttraumatic stress disorder.
Pace TW; Wingenfeld K; Schmidt I; Meinlschmidt G; Hellhammer DH; Heim CM
Brain Behav Immun; 2012 Jan; 26(1):13-7. PubMed ID: 21801830
[TBL] [Abstract][Full Text] [Related]
36. Mononuclear leukocyte glucocorticoid receptor binding characteristics and down-regulation in major depression.
Wassef A; Smith EM; Rose RM; Gardner R; Nguyen H; Meyer WJ
Psychoneuroendocrinology; 1990; 15(1):59-68. PubMed ID: 2367616
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of glucocorticoid-induced changes of Na(+), K(+)-ATPase in rat lens by a glucocorticoid receptor antagonist RU486.
Xie GL; Yan H; Lu ZF
Exp Eye Res; 2010 Oct; 91(4):544-9. PubMed ID: 20637751
[TBL] [Abstract][Full Text] [Related]
38. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy.
Mimrod D; Specchio LM; Britzi M; Perucca E; Specchio N; La Neve A; Soback S; Levy RH; Gatti G; Doose DR; Maryanoff BE; Bialer M
Epilepsia; 2005 Jul; 46(7):1046-54. PubMed ID: 16026556
[TBL] [Abstract][Full Text] [Related]
39. Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial.
Ramsay E; Faught E; Krumholz A; Naritoku D; Privitera M; Schwarzman L; Mao L; Wiegand F; Hulihan J;
Epilepsia; 2010 Oct; 51(10):1970-7. PubMed ID: 20633037
[TBL] [Abstract][Full Text] [Related]
40. NFκB and glucocorticoid receptor activity in steroid resistance.
Dawson C; Dhanda A; Conway-Campbell B; Dimambro A; Lightman S; Dayan C
J Recept Signal Transduct Res; 2012 Feb; 32(1):29-35. PubMed ID: 22185489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
